Return to homepagePandemic Pact

to identify novel compounds inhibiting henipavirus replication for pandemic antiviral preparedness

Grant number: INV-048877

Grant search

Key facts

  • Disease

    Unspecified

  • start year

    2022

  • Known Financial Commitments (USD)

    $1,996,634

  • Funder

    Gates Foundation

  • Principal Investigator

    N/A

  • Research Location

    United States of America

  • Lead Research Institution

    Icahn School of Medicine at Mount Sinai

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

N/A

Publicationslinked via Europe PMC

Last Updated:43 minutes ago

View all publications at Europe PMC

Tetracistronic minigenomes elucidate a functional promoter for Ghana virus and unveils Cedar virus replicase promiscuity for all henipaviruses.